Giulio Draetta named Chief Scientific Officer
The University of Texas MD Anderson Cancer Center has named Giulio Draetta, M.D., Ph. D. as chief scientific officer (CSO), a new position that champions innovation, develops strong partnerships and provides focused leadership on the science and clinical translation of research programs. He held appointments at Pharmacia and Merck, as vice president and as worldwide head of oncology drug discovery, and he has served as an investigator at the Cold Spring Harbor Laboratory, the European...